Stock Taper
SCREENER COMPARE ANY 2 STOCKS
SUPN
SUPERNUS PHARMACEUTICALS, INC.
NASDAQ
$43.53
▼ DOWN 1.00% (-0.44)

KEY STATISTICS

Market Cap$2.54 B
52w High$59.68
52w Low$42.45
Dividend Yield—
Frequency—
P/E14.23
Volume444.20K
Shares Out.58.04M

COMPANY

LEADERSHIP

Jack A. Khattar
CHIEF EXECUTIVE
Jack A. Khattar

COMPENSATION 2026

Salary$1,036,000
Stock Awards$6,535,029
Incentive Plan Pay$846,930
All Other Comp.$52,053
Total$15,501,557

ABOUT

SECTOR
Healthcare
WENT PUBLIC
May 1, 2012
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
778

PRICE TARGET

Target High$65.00
Target Low$40.00
Target Median$63.00
Target Consensus$57.60

UPCOMING EARNINGS

DateNov 3, 2026
DayTuesday
Rev. Est.$218.29M
NOV
3
TUE

PRICE

$43.53 ▼ DOWN 1.00% (−$0.44)
$43.60$43.80$44.009:31 AM10:36 AM11:40 AM12:45 PM1:50 PM2:54 PM3:59 PM43.53

About Supernus Pharmaceuticals, Inc.

https://www.supernus.com ↗

Supernus Pharmaceuticals develops and markets CNS-focused treatments like epilepsy, migraine, ADHD, and Parkinson's disease therapies, with several products and candidates in various clinical stages.

INDUSTRY

Drug Manufacturers - Specialty & Generic

A PRODUCT SUPERNUS PHARMACEUTICALS, INC. IS KNOWN FOR

Onapgo (apomorphine hydrochloride)
Onapgo (apomorphine hydrochloride)

Onapgo, FDA-approved in Q2 2025, is a wearable, subcutaneous infusion device for continuous treatment of OFF episodes in adults with advanced Parkinson's disease, marking a key innovation in Supernus's Parkinson's portfolio.

COMPETITORS

COMPETITOR
ABBV COMPARE
ACAD COMPARE
AMRX COMPARE
JAZZ COMPARE
TEVA COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Product$168.54M $158.01M ▼$150.75M ▼$165.71M ▲
Qelbree$81.42M $80.95M ▼$77.84M ▼$89.24M ▲
GOCOVRI$40.85M $38.63M ▼$35.24M ▼$37.53M ▲
Collaboration Revenue$20.16M $32.83M ▲$27.64M ▼$35.35M ▲
Royalty License And Other Revenue$3.4M $20.73M ▲$29.31M ▲$18M ▼
Oxtellar X R$12.02M $6.85M ▼$7.42M ▲$8.78M ▲
Trokendi Xr$10.04M $8.38M ▼$9.48M ▲$8.41M ▼
APOKYN$10.39M $9.59M ▼$7.73M ▼$6.32M ▼
Manufactured Product Other$7.03M $4.77M ▼$4.67M ▼$1.88M ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
215
LISTED HERE
26
RANKED BY POSITION SIZE
XAW.TO
0.00% · 3.5M
VTS.AX
0.00% · 1.8M
AFTY
1.95% · 1.7M
SPSM
0.14% · 534.0K
SCHA
0.05% · 277.2K
FESM
0.17% · 252.3K
DFAT
0.07% · 222.9K
AVSC
0.17% · 119.2K
FTXH
0.34% · 84.5K
PRFZ
0.11% · 67.6K
XRSG.L
0.08% · 49.0K
GSSC
0.19% · 47.8K
SIXS
0.83% · 37.2K
PSIL
2.76% · 35.2K
JPSE
0.24% · 32.9K
EES
0.18% · 29.1K
RSSL
0.08% · 26.9K
FSCC
0.11% · 10.9K
MRGR
2.20% · 8.0K
ROSC
0.61% · 7.5K
RTWP.L
0.13% · 6.7K
ZSML.TO
0.14% · 5.4K
PILL
1.00% · 5.2K
AFSC
2.24% · 5.1K
TILT
0.01% · 3.9K
SQLV
0.35% · 3.2K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
91.80%
HOLDERS
507
TOP 12 OF 507 · RANKED BY POSITION SIZE
Blackrock Inc.
10.4M sh · $278M
Blackrock, Inc.
9.4M sh · $434.87M
Vanguard Group Inc
6.0M sh · $300.61M
Armistice Capital, LLC
4.8M sh · $151.67M
Blackrock Fund Advisors
4.4M sh · $112.23M
Millennium Management LLC
3.9M sh · $179.21M
Dimensional Fund Advisors LP
3.0M sh · $143.46M
Macquarie Group Ltd
2.5M sh · $120.98M
State Street Corp
2.5M sh · $114.41M
Macquarie Management Holdings, Inc.
2.4M sh · $110.62M
Point72 Asset Management, L.P.
2.3M sh · $112.56M
Renaissance Technologies LLC
1.7M sh · $83.18M

RATINGS SNAPSHOT

Overall rating: B-

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book3
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
Gilbert Cisneros
Gilbert Cisneros
Purchase
2025-12-11
 Gilbert Ray Cisneros
Gilbert Ray Cisneros
Purchase
2025-12-11
 Josh Gottheimer
Josh Gottheimer
Sale (Partial)
2022-12-23
 Josh S. Gottheimer
Josh S. Gottheimer
Sale (Partial)
2022-12-23

INSIDER TRADES

★
OFFICER: SVP, CHIEF MEDICAL OFFICER
Rubin Jonathan
Sale · 363 shares
2026-08-12
★
OFFICER: SENIOR VICE-PRESIDENT & CFO
DEC TIMOTHY C
Sale · 1.3K shares
2026-08-12
★
OFFICER: SVP, CHIEF MEDICAL OFFICER
Rubin Jonathan
Sale · 750 shares
2026-08-12
★
OFFICER: SENIOR VICE-PRESIDENT & CFO
DEC TIMOTHY C
Sale · 604 shares
2026-08-12

MOST RECENT ANALYST GRADES

GRADE SUMMARY
OVERWEIGHT 2
HOLD 1
BUY 1
4 GRADES IN THE LAST 12 MONTHS
Cantor Fitzgerald OVERWEIGHT Stifel HOLD TD Cowen BUY Piper Sandler OVERWEIGHT

SECTORS PEERS

PEERPRICE
LNTH$100.97COMPARE
CGON$74.47COMPARE
XENE$59.77COMPARE
AMRX$17.42COMPARE
INDV$35.01COMPARE
GRAL$79.75COMPARE
HCM$14.17COMPARE
BHC$6.58COMPARE